MEMichelle A. Emrick

Michelle A. Emrick

*This is an algorithmically generated author record based on publicly available information.

Michelle A. Emrick has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew N. Hoofnagle

    Department of Laboratory Medicine & Pathology, University of Washington , Seattle, WA

    2 shared publications
  • Benjamin Y. Owusu

    Departments of Laboratory Medicine and Pathology, USA

    1 shared publication
  • Clark M. Henderson

    Departments of Laboratory Medicine and Pathology, USA

    1 shared publication
  • Elisha Goonatilleke

    Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA

    1 shared publication
  • Jessica O. Becker

    Departments of Laboratory Medicine and Pathology, USA

    1 shared publication
  • Junyan Shi

    Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver Coastal Health, Vancouver, BC, Canada; Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada

    1 shared publication

Latest Publications

  • Open Access

    A distributable LC-MS/MS method for the measurement of serum thyroglobulin

    by Junyan Shi, William S. Phipps, Benjamin Y. Owusu, Clark M. Henderson, Thomas J. Laha, Jessica O. Becker, Morteza Razavi, Michelle A. Emrick, Andrew N. Hoofnagle

    Despite its clear advantages over immunoassay-based testing, the measurement of serum thyroglobulin by mass spectrometry remains limited to a handful of institutions. Slow adoption by clinical laboratories could reflect limited accessibility to existing methods that have sensitivity comparable to modern immunoassays, as well as a lack of tools for calibration and assay harmonization. We developed and validated a liquid chromatography-tandem mass spectrometry-based assay for the quantification of serum thyroglobulin. The protocol combined peptide immunoaffinity purification using a commercially available, well-characterized monoclonal antibody and mobile phase modification with dimethylsulfoxide (DMSO) for enhanced sensitivity. To facilitate harmonization with other laboratories, we developed a novel, serum-based 5-point distributable reference material (Husky Ref). The assay demonstrated a lower limit of quantification of 0.15 ng/mL (<20 %CV). Mobile phase DMSO increased signal intensity of the target peptide at least 3-fold, improving quantification at low concentrations. Calibration traceable to Husky Ref enabled harmonization between laboratories in an interlaboratory study. Sensitive mass spectrometry-based thyroglobulin measurement can be achieved using a monoclonal antibody during peptide immunoaffinity purification and the addition of mobile phase DMSO. Laboratories interested in deploying this assay can utilize the provided standard operating procedure and freely-available Husky Ref reference material.


  • Open Access

    Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies

    by North Foulon, Elisha Goonatilleke, Michael J. MacCoss, Michelle A. Emrick, Andrew N. Hoofnagle

    The measurement of insulin and C-peptide provides a valuable tool for the clinical evaluation of hypoglycemia. In research, these biomarkers are used together to better understand hyperinsulinemia, hepatic insulin clearance, and beta cell function. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is an attractive approach for the analysis of insulin and C-peptide because the platform is specific, can avoid certain limitations of immunoassays, and can be multiplexed. Previously described LC-MS/MS methods for the simultaneous quantification of insulin and C-peptide measure the intact analytes and most have relied on immunoaffinity enrichment. These approaches can be limited in terms of sensitivity and interference from auto-antibodies, respectively. We have developed a novel method that does not require antibodies and uses proteolytic digestion to yield readily ionizable proteotypic peptides that enables the sensitive, specific, and simultaneous quantitation of insulin and C-peptide. Serum samples were precipitated with acetonitrile. Analytes were enriched using solid phase extraction and then digested with endoproteinase Glu-C. Surrogate peptides for insulin and C-peptide were analyzed using targeted LC-MS/MS. Inter-day imprecision was below 20 %CV and linearity was observed down to the lower limit of quantitation for both analytes (insulin = 0.09 ng/mL, C-peptide = 0.06 ng/mL). Comparison to a commercially available insulin immunoassay (Beckman Coulter UniCel DxI 600 Access) revealed a 30% bias between methods. A novel LC-MS/MS method for the simultaneous analysis of insulin and C-peptide using Glu-C digestion was developed and evaluated. A detailed standard operating procedure is provided to help facilitate implementation in other laboratories.